| Literature DB >> 30455680 |
Isidro García-Meniño1, Vanesa García1, Azucena Mora1, Dafne Díaz-Jiménez1, Saskia C Flament-Simon1, María Pilar Alonso2, Jesús E Blanco1, Miguel Blanco1, Jorge Blanco1.
Abstract
This is a wide epidemiological study of 499 E. coli isolates recovered from 179 outbreaks of enteric colibacillosis from pig production farms in Spain during a period of 10 years. Most samples were of diarrheagenic cases occurred during the post-wean period (PWD) which showed to be significantly associated with ETEC (67%) followed by aEPEC (21.7%). On the contrary, aEPEC was more prevalent (60.3%) among diarrheas of suckling piglets, followed by ETEC (38.8%). STEC/ETEC or STEC were recovered in 11.3 and 0.9% of PWD and neonatal diarrhea, respectively. Detection of the F4 colonization factor was not significantly different between isolates recovered from neonatal pigs and those recovered post wean (40.5 versus 27.7%) while F18 was only present among PWD isolates (51.5% of ETEC, STEC, and STEC/ETEC isolates). We also found a high prevalence of resistance to colistin related to the presence of the mcr-1 gene (25.6% of the diarreagenic isolates). The characterization of 65 representative mcr-1 isolates showed that all were phenotypically resistant to colistin (>2 μg/ml), and most (61 of 65) multidrug-resistant (MDR). Six ETEC and one STEC mcr-1 isolates were also carriers of ESBL genes. In addition, other seven mcr-1 isolates harbored mcr-4 (three ETEC) and mcr-5 (two ETEC and two aEPEC) genes. In the phylogenetic analysis of the 65 mcr-1 diarrheagenic isolates we found that more than 50% (38 out of 65) belonged to A-ST10 Cplx and from those, 29 isolates showed the clonotype CH11-24. In this study, we also recovered 18 ST131 isolates including seven mcr-1 carriers. To the best of our knowledge, this would be the first report of ST131 mcr-1 isolation in pigs. Worryingly, the swine mcr-1 ST131 carriers also showed MDR, including to trimethoprim-sulfamethoxazole, tobramycin, gentamicin and ciprofloxacin. In the PFGE-macrorestriction comparison of clinical swine and human ST131, we found high similarities (≥85%) between two pig and two human ST131 isolates of virotype D5. Acquisition of mcr-1 by this specific clone means an increased risk due to its special feature of congregating virulence and resistance traits, together with its spread capability. Here we show a potential zoonotic swine source of ST131.Entities:
Keywords: E. coli; EPEC; ETEC; ST10; ST131; STEC; mcr-1; post-weaning diarrhea
Year: 2018 PMID: 30455680 PMCID: PMC6230658 DOI: 10.3389/fmicb.2018.02659
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Association between serogroups, pathotypes, and presence of mcr-1 gene among the 481 E. coli isolates involved in swine colibacillosis (Spain, 2006–2016).
| Serogroupa | ETEC | aEPEC | STEC/ETEC | STEC | |
|---|---|---|---|---|---|
| O2 | 1 (0.4) | 6 (3.8) | – | 2 (13.3) | |
| O4 | – | 2 (1.3) | – | – | – |
| O5 | 1 (0.4) | 1 (0.6) | – | – | 1(0.8) |
| O7 | 3 (1.1) | – | – | – | 2 (1.6) |
| O8 | 4 (1.4) | – | – | – | 1 (0.8) |
| O14 | 1 (0.4) | – | – | – | – |
| O15 | 7 (2.5) | 5 (3.2) | – | – | |
| O20 | 4 (1.4) | 1 (0.6) | – | – | – |
| O22 | – | – | – | 1 (6.7) | – |
| O26 | – | – | – | ||
| O28 | – | 1 (0.6) | – | – | – |
| O35 | 5 (1.8) | – | – | – | 2 (1.6) |
| O36 | 1 (6.7) | 1(0.8) | |||
| O39 | – | 1 (0.6) | – | – | – |
| O45 | 9 (3.2) | 2 (1.3) | – | – | |
| O49 | – | – | – | – | |
| O51 | – | 2 (1.3) | – | – | 1 (0.8) |
| O55 | – | 1 (0.6) | – | – | – |
| O65 | – | – | 1 (3) | – | – |
| O76 | – | 6 (3.9) | – | – | – |
| O80 | – | – | – | – | |
| O81 | 1 (0.6) | 1(0.8) | |||
| O86 | – | – | 1 (3) | – | – |
| O88 | 1 (0.4) | 1 (0.6) | – | – | 1(0.8) |
| O98 | 2 (0.7) | – | – | – | – |
| O101 | 5 (1.8) | – | – | – | – |
| O103 | – | 5 (3.2) | – | – | 2 (1.6) |
| O108 | 3 (1.9) | – | – | – | |
| O111 | – | – | – | ||
| O115 | – | 2 (1.3) | – | – | – |
| O118 | 1 (0.4) | 1 (0.6) | – | – | 1 (0.8) |
| O123 | – | 5 (3.2) | – | – | 3 (2.4) |
| O127 | – | 2 (1.3) | – | – | – |
| O137 | 1 (0.4) | – | – | – | – |
| O138 | – | – | |||
| O139 | – | – | – | 1 (0.8) | |
| O141 | – | – | |||
| O142 | – | – | – | 1 (6.7) | – |
| O145 | – | 6 (3.9) | – | – | 2 (1.6) |
| O147 | 2 (0.7) | – | – | – | – |
| O149 | – | – | – | – | |
| O153 | – | 7 (4.5) | – | – | – |
| O157 | 7 (4.5) | 1 (3) | – | ||
| O158 | – | – | – | 1 (6.7) | – |
| O159 | 1(0.4) | – | 1 (3) | – | 1 (0.8) |
| O163 | 1 (0.4) | – | – | – | – |
| O169 | 1 (0.4) | – | – | – | – |
| O174 | – | 1 (0.6) | – | – | – |
| O177 | – | 3 (1.9) | – | – | 1 (0.8) |
| O180 | – | 1 (0.6) | – | – | – |
| ONT | 80 (28.9) | 22 (14.1) | 10 (30.3) | 2 (13.3) | 9 (7.3) |
Molecular characterization of the 41 ETEC, STEC, and STEC/ETEC mcr-1-positive isolates.
| Pathotype (No. isolates) | Serotypea-PG-ST | CHb | No. isolates | ESBL typing (No. isolates) | Virulence gene profile (No. isolates) | Resistance profilec (isolates with |
|---|---|---|---|---|---|---|
| ETEC (33) | O141:H4-A-ST10 | 11-24 | 2 | – | STa, STb, F18ac, HlyA (1) | AMP AMP/SAM CHL COL GEN TI TMP/SMX TOB |
| STa, STb (1) | AMP AMP/SAM CHL COL GEN TI TMP/SMX TOB | |||||
| O157:HNM-A-ST10 | 11-24 | 10 | CTX-M-14 (3) | LT, STb, K88ac, HlyA (5) | AMP AMP/SAM ATM COL CTX FEP MI NAL TI | |
| AMP AMP/SAM CHL COL CTX FEP MI NAL TI TMP/SMX | ||||||
| AMP AMP/SAM COL CTX FEP GEN MI NAL TI TMP/SMX TOB | ||||||
| AMP AMP/SAM COL GEN MI NAL TI TMP/SMX TOB | ||||||
| CIP COL LEV MI NAL | ||||||
| LT, STb, K88ac (2) | AMP AMP/SAM COL GEN MI NAL TI TMP/SMX TOB | |||||
| COL MI NAL TMP/SMX | ||||||
| LT, STb, HlyA (1) | AMP COL GEN MI NAL TI TMP/SMX TOB | |||||
| LT, K88ac, HlyA (1) | AMP AMP/SAM COL GEN MI NAL TI TMP/SMX TOB | |||||
| LT, STb, K88ac, HlyA (1) | AMP COL GEN MI NAL TI TMP/SMX TOB | |||||
| 11-0 | 1 | LT, STb, K88ac, HlyA (1) | AMP AMP/SAM COL GEN NAL TI TMP/SMX TOB | |||
| O45:HNM-A-ST10 | 11-24 | 1 | – | LT, F18ac, HlyA (1) | AMP AMP/SAM CIP COL GEN LEV NAL TI TMP/SMX TOB | |
| ONT:HNM-A-ST10 | 11-24 | 1 | – | LT, F18ac, HlyA (1) | AMP AMP/SAM CIP COL GEN LEV NAL TI TMP/SMX TOB | |
| 11-94 | 2 | CTX-M-14 (1) | STa, STb (1) | AMP AMP/SAM CHL COL GEN NAL TI TMP/SMX TOB | ||
| STa, STb, F18ac, HlyA (1) | AMP AMP/SAM ATM CHL CIP COL CTX FEP GEN LEV NAL TI TMP/SMX TOB | |||||
| O35:H6-A-ST10 | 11-45 | 1 | – | STb (1) | AMP COL NAL TI | |
| O141:H4-A-ST5786 | 11-24 | 5 | CTX-M-14 (1) | STa, STb, F18ac, HlyA (2) | AMP COL TMP/SMX | |
| COL FOS MI TMP/SMX NAL | ||||||
| STa, F18ac, HlyA (1) | AMP AMP/SAM ATM CHL COL CTX FEP MI NAL TI | |||||
| STa, STb, F18ac, HlyA (1) | AMP CHL COL GEN NAL TI TMP/SMX TOB | |||||
| STa, STb, F18ac, HlyA (1) | CHL COL FOS TMP/SMX | |||||
| O7:H4-A-ST93 | 11-27 | 1 | SHV-12 (1) | STb (1) | AMP AMP/SAM ATM CAZ CHL COL CTX TI | |
| O138:H10-A-ST100 | 27-0 | 2 | – | LT, STb, K88ac, HlyA (1) | AMP AMP/SAM COL GEN MI NAL TI TOB | |
| STb, K88ac, HlyA (1) | COL MI TMP/SMX | |||||
| O8:HNM-A-ST398 | 7-171 | 1 | – | STb (1) | CHL COL | |
| O157:HNM-B1-ST156 | 29-38 | 1 | – | STb (1) | AMP AMP/SAM CHL CIP COL LEV MI NAL TI TMP/SMX TOB | |
| O138:H14-E-ST42 | 28-65 | 3 | – | LT, STa, STb, F18ac, HlyA (1) | AMP AMP/SAM CIP COL ∗FOS LEV MI NAL TI | |
| LT, STb, F18ac, HlyA (1) | AMP AMP/SAM CHL COL ∗FOS TI TMP/SMX NAL | |||||
| LT, STa, STb, F18ac, HlyA (1) | CHL COL ∗FOS GEN TOB NAL | |||||
| O15:H45-E-ST118 | 4-331 | 1 | – | STb (1) | AMP AMP/SAM CHL COL GEN MI NAL TI TOB | |
| O45:H45-E-ST4247 | 550-400 | 1 | – | STb (1) | COL NAL | |
| STEC/ETEC (5) | O141:H4-A-ST10 | 11-24 | 5 | – | STa, STb, Stx2e, F18ac, HlyA (3) | AMP AMP/SAM CHL COL ∗FOS GEN TI TMP/SMX TOB (2) |
| AMP AMP/SAM CHL COL TI TMP/SMX | ||||||
| STa, STb, Stx2e, F18ac HlyA (2) | AMP AMP/SAM CHL COL GEN TI TMP/SMX TOB (2) | |||||
| STEC (3) | O2:HNM-A-ST10 | 11-23 | 1 | – | Stx2e, HlyA (1) | AMP AMP/SAM CHL COL FOS MI NAL TI TMP/SMX |
| O141:HNM-A-ST10 | 11-24 | 1 | CTX-M-14 (1) | Stx2e (1) | AMP AMP/SAM ATM CHL COL CTX FEP GEN TI TMP/SMX TOB | |
| O139:H1-E-ST1 | 2-54 | 1 | – | Stx2e, F18ab, HlyA (1) | AMP COL MI TI TMP/SMX |
Molecular characterization of the 24 aEPEC mcr-1-positive isolates.
| Serotypea-PG-ST | CHb | No. isolates | Intimin typec (No. isolates) | Resistance profiled (isolates with |
|---|---|---|---|---|
| O2:H40-A-ST10 | 11-24 | 4 | AMP AMP/SAM COL TI | |
| AMP AMP/SAM CHL COL MI TI TMP/SMX | ||||
| AMP AMP/SAM CHL COL GEN TI TMP/SMX TOB | ||||
| CHL COL GEN TMP/SMX TOB | ||||
| O26:H11-A-ST48 | 11-54 | 3 | AMP AMP/SAM CHL COL TI | |
| CHL COL GEN NAL TMP/SMX TOB | ||||
| AMP AMP/SAM COL NAL TI TMP/SMX | ||||
| O157:H2-A-ST301 | 27-54 | 2 | AMP AMP/SAM CHL COL MI NAL TI TMP/SMX | |
| AMP AMP/SAM CHL CIP COL GEN MI NAL TI TOB | ||||
| O45:H2-A-ST301 | 27-54 | 1 | AMP AMP/SAM COL TI | |
| O157:H2-A-STNew1 | 27-54 | 1 | CHL COL GEN MI NAL TMP/SMX TOB | |
| O26:H11-A-ST7367 | 685-54 | 1 | COL MI | |
| O103:H2-B1-ST20 | 4-25 | 1 | AMP AMP/SAM COL TI TMP/SMX | |
| O111:H9-B1-ST29 | 4-24 | 2 | AMP AMP/SAM CHL COL ∗FOS NAL TI TMP/SMX | |
| CHL COL ∗FOS NAL TMP/SMX | ||||
| O118:H9-B1-ST29 | 4-24 | 1 | COL NAL TMP/SMX | |
| O123:H11-B1-ST29 | 4-24 | 3 | AMP CHL COL NAL TI TMP/SMX | |
| COL MI | ||||
| CHL COL NAL TMP/SMX | ||||
| O177:H11-B1-ST29 | 4-440 | 1 | AMP AMP/SAM CHL CIP COL GEN LEV MI NAL TI TMP/SMX TOB | |
| O26:H11-B1-ST29 | 4-440 | 1 | AMP AMP/SAM CHL COL ∗FOS TI | |
| O51:H9-B1-ST29 | 4-24 | 1 | AMP AMP/SAM CHL COL TI TMP/SMX | |
| O145:H28-E-ST1034 | 23-331 | 1 | AMP AMP/SAM CHL COL GEN TI TMP/SMX TOB | |
| O45:H9-E-ST302 | 84-305 | 1 | AMP AMP/SAM CHL COL GEN MI NAL TI TMP/SMX TOB |
Prevalence of antimicrobial resistances among the 65 mcr-1 diarrheagenic E. coli.
| Antimicrobial agent | No. of resistant isolates (%)a |
|---|---|
| Colistin | 65 (100) |
| Ampicillin | 49 (75.4) |
| Ticarcillin | 48 (73.8) |
| Ampicillin-sulbactam | 42 (64.6) |
| Aztreonam | 5 (7.7) |
| Ceftazidime | 1 (1.5) |
| Cefepime | 6 (9.2) |
| Cefotaxime | 7 (10.8) |
| Gentamicin | 31 (47.7) |
| Tobramycin | 31 (47.7) |
| Minocycline | 27 (41.5) |
| Fosfomycin | 3 (4.6)b |
| Chloramphenicol | 38 (58.5) |
| Trimethoprim-sulfamethoxazole | 47 (72.3) |
| Nalidixic acid | 39 (60.0) |
| Ciprofloxacin | 8 (12.3) |
| Levofloxacin | 7 (10.8) |
FIGURE 1Phylogenetic tree based on concatenated sequences of the seven housekeeping genes from the MLST Achtman scheme by the neighbor-joining method using MEGA6. The analysis includes the 19 STs determined for the mcr-1 (65 diarrheagenic and seven ST131-B2) positive isolates. Numbers on the tree indicate bootstrap values calculated for 1,000 replicates. Colors indicate: blue (phylogroup A), orange (phylogroup B1), green (phylogroup B2), and red (phylogroup E). Pathotype and number of isolates (in parentheses) are shown on the right.
Phenotypic and genotypic characterization of the 18 O25b:H4-B2-ST131 isolates recovered from the 464 fecal samples of pigs with diarrhea.
| CHa | Virulence profileb | Virotypec | No. of isolates/resistance profiled | |
|---|---|---|---|---|
| CH40-22 | D-nt | |||
| D5 | 1 | AMP AMP/SAM NAL TI | ||
| D5 | ||||
| D2 | 1 | AMP AMP/SAM MI TI | ||
| D5 | ||||
| D5 | ||||
| D-nt | 1 | - | ||
| CH40-161 | D5 | 1 | AMP AMP/SAM NAL TI | |
| 1 | AMP AMP/SAM TI | |||
| CH40-326 | D5 | 1 | AMP AMP/SAM NAL TI | |
| CH40-330 | D2 | 1 | – | |
| CH40-332 | D5 | 1 | AMP AMP/SAM GEN NAL TI TOB TMP/SMX | |
| CH40-374 | D5 | 2 | AMP AMP/SAM TI | |
| CH40-336 | D5 | 1 | AMP AMP/SAM CHL NAL TI | |
| CH40-338 | D5 | |||
FIGURE 2PFGE macrorrestriction profile of 17 pig E. coli isolates belonging to the clonal group O25:H4-B2-ST131 (one ST131 isolate resulted autodigested) compared with two human clinical isolates of the LREC collection (showed in blue): association between isolation code, virotype, year, and origin of isolation (P, pig; H, human), mcr-1 presence, and virulence profile is indicated on the right. Highlighted in red clusters of similarity >85%.